These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19995689)

  • 1. [Management of retroperitoneal lymphadenectomy in advanced epithelial ovarian cancer].
    Jaffré I; Bordes V; Dejode M; Dravet F; Classe JM
    Bull Cancer; 2010 Jan; 97(1):65-71. PubMed ID: 19995689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
    Classe JM; Cerato E; Boursier C; Dauplat J; Pomel C; Villet R; Cuisenier J; Lorimier G; Rodier JF; Mathevet P; Houvenaeghel G; Leveque J; Lécuru F
    J Gynecol Obstet Biol Reprod (Paris); 2011 May; 40(3):201-4. PubMed ID: 21482037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of retroperitoneal lymph nodes in the treatment of ovarian cancer.
    Ushijima K
    Int J Clin Oncol; 2007 Jun; 12(3):181-6. PubMed ID: 17566840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
    Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retroperitoneal lymph node metastasis in patients with ovarian cancer].
    Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
    J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.
    Fang C; Zhang Y; Zhao L; Chen X; Xia L; Zhang P
    BMC Cancer; 2020 Jul; 20(1):654. PubMed ID: 32660444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
    Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer.
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of retroperitoneal lymph nodes in advanced ovarian cancer.
    Hacker NF; Valmadre S; Robertson G
    Int J Gynecol Cancer; 2008; 18 Suppl 1():7-10. PubMed ID: 18336392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A; Baloglu A; Cetinkaya B
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
    Spirtos NM; Gross GM; Freddo JL; Ballon SC
    Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Aletti GD; Dowdy S; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Node clearance in ovarian cancer].
    Villet R; Salet-Lizee D
    Bull Acad Natl Med; 2010 Jan; 194(1):39-49; discussion 49-50. PubMed ID: 20669558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients.
    Iwase H; Takada T; Iitsuka C; Nomura H; Abe A; Taniguchi T; Takizawa K
    J Gynecol Oncol; 2015 Oct; 26(4):303-10. PubMed ID: 26197771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
    Salet-Lizée D; Alsary S
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy in the surgical management of penile cancer.
    Protzel C; Alcaraz A; Horenblas S; Pizzocaro G; Zlotta A; Hakenberg OW
    Eur Urol; 2009 May; 55(5):1075-88. PubMed ID: 19264390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.